FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 51 through 100 of 146

PHARMACEUTICAL PREPARATIONS - SIC # 2834

Ticker Exchange Company Financial Reports SIC #
EVMN New York Evommune, Inc. 2834
EVO Nasdaq Evotec SE 2834
FBRX Nasdaq Forte Biosciences, Inc. 2834
GBIO Nasdaq Generation Bio Co. 2834
GHRS Nasdaq GH Research PLC 2834
GLPG Nasdaq Galapagos NV 2834
GRI Nasdaq GRI Bio, Inc. 2834
GSK New York GSK plc 2834
HIND Nasdaq Vyome Holdings, Inc. 2834
HOTH Nasdaq Hoth Therapeutics, Inc. 2834
HOWL Nasdaq Werewolf Therapeutics, Inc. 2834
HROW Nasdaq Harrow, Inc. 2834
HYPD Nasdaq Hyperion DeFi, Inc. 2834
HYPMY Over the counter Hypera S.A. 2834
IDYA Nasdaq IDEAYA Biosciences, Inc. 2834
IMRN Nasdaq Immuron Limited 2834
IMRX Nasdaq Immuneering Corporation 2834
INBX Nasdaq Inhibrx Biosciences, Inc. 2834
INKT Nasdaq MiNK Therapeutics, Inc. 2834
IOBT Nasdaq IO Biotech, Inc. 2834
IVA Nasdaq Inventiva S.A. 2834
JAGX Nasdaq Jaguar Health, Inc. 2834
JNJ New York Johnson & Johnson 2834
KLTO Nasdaq Klotho Neurosciences, Inc. 2834
KRYS Nasdaq Krystal Biotech, Inc. 2834
KZIA Nasdaq Kazia Therapeutics Limited 2834
LCTX Lineage Cell Therapeutics, Inc. 2834
LLY New York Eli Lilly and Company 2834
LPCN Nasdaq Lipocine Inc. 2834
LZAGY Over the counter Lonza Group AG 2834
MAZE Nasdaq Maze Therapeutics, Inc. 2834
MENS Nasdaq Jyong Biotech Ltd. 2834
MLTX Nasdaq MoonLake Immunotherapeutics 2834
MLYS Nasdaq Mineralys Therapeutics, Inc. 2834
MREO Nasdaq Mereo BioPharma Group plc 2834
MRK New York Merck & Co., Inc. 2834
MTVA Nasdaq MetaVia Inc. 2834
NAMS Nasdaq NewAmsterdam Pharma Company N.V. 2834
NBIX Nasdaq Neurocrine Biosciences, Inc. 2834
NRSN Nasdaq NeuroSense Therapeutics Ltd. 2834
NTLA Nasdaq Intellia Therapeutics, Inc. 2834
NTRB Nasdaq Nutriband Inc. 2834
NVAX Nasdaq Novavax, Inc. 2834
OCGN Nasdaq Ocugen, Inc. 2834
OCS Nasdaq Oculis Holding AG 2834
OMER Nasdaq Omeros Corporation 2834
ONC Nasdaq BeOne Medicines AG 2834
ORGO Nasdaq Organogenesis Holdings Inc. 2834
ORINY Over the counter Orion Oyj 2834
ORMP Nasdaq Oramed Pharmaceuticals Inc. 2834
Results 50 through 100 of 146